Shares of Rezolve AI Ltd (NASDAQ:RZLV) rose 11.7% on Tuesday after shareholders gave the company the green light at its Annual General Meeting to pursue a capital reduction and a share repurchase program with a ceiling of $300 million.
The authorization provides the company's board with discretion to acquire ordinary shares, but only after obtaining approval from the UK Court under the UK Companies Act 2006. Rezolve AI expects the Court to grant that approval by mid-September 2026 and plans to begin repurchases as soon as practicable thereafter, subject to market conditions and the Board's judgment.
Company disclosures emphasize that the repurchase program is flexible in execution. Repurchases may occur via open market purchases, block trades, or privately negotiated transactions. The program does not compel Rezolve AI to purchase any specific number of shares and may be suspended or modified at any time.
The approved buyback follows a period of notable operating momentum. Rezolve AI reported approximately $60 million in unaudited revenue for the first quarter of 2026, a quarterly total the company said exceeds its full-year 2025 revenue. Management reaffirmed fiscal year 2026 guidance of roughly $360 million in revenue, a figure the company characterized as approximately 7.5 times its fiscal year 2025 revenue baseline.
In addition to the revenue targets, Rezolve AI stated it expects to exit 2026 with at least $500 million in annual recurring revenue. The company now counts more than 1,000 enterprise customers around the world.
Rezolve AI's commercial offering is anchored by its Brain Suite platform. According to the company's description, Brain Suite enables retailers, brands and financial institutions to deploy intelligent search, conversational engagement, personalized recommendations and AI-powered transaction execution.
Investors should note the procedural conditions attached to the repurchase program and the unaudited status of the first quarter revenue figure as described by the company. Beyond those procedural qualifiers, the board retains discretion over timing, transaction method and whether any aggregate repurchases are made at all.
Market context and procedural notes
The buyback authorization and the reported quarter results are presented as distinct but related developments. The share repurchase program will only proceed after UK Court approval and at the Board's discretion, while the reported first quarter revenue figure is unaudited and was used to reaffirm full-year 2026 guidance.